172 filings
Page 4 of 9
CORRESP
sr77g 48674s9e4
30 Jun 23
Correspondence with SEC
12:00am
UPLOAD
nidna39fd3 8yrfi
28 Jun 23
Letter from SEC
12:00am
424B3
3edl d9sm3z70x3g
12 Jun 23
Prospectus supplement
12:00am
8-K
8zx68
12 Jun 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
S-8
2lk5o5 527rmjzbsm6o
19 May 23
Registration of securities for employees
5:27pm
424B3
ttj6zcp7 paqkbmh46w
19 May 23
Prospectus supplement
4:52pm
8-K
wb31iflzvoqffp
19 May 23
ZyVersa Therapeutics Announces Changes to ZyVersa Board of Directors
4:30pm
424B3
kz0abdy0zzmgw9fnj
12 May 23
Prospectus supplement
9:15pm
8-K
8ictovy
12 May 23
ZyVersa Therapeutics Reports First Quarter 2023 Corporate and Financial Results
9:13pm
424B3
yb1mhasppgnp40
12 May 23
Prospectus supplement
1:42pm
424B4
c0ttlc4
28 Apr 23
Prospectus supplement with pricing info
2:05pm
POS EX
h2od51v3jn56hhbt
28 Apr 23
Additional exhibits for listing
11:19am
EFFECT
fosmn4w5slrf9kviu
27 Apr 23
Notice of effectiveness
12:15am
CORRESP
qt4cen73j2zf
25 Apr 23
Correspondence with SEC
12:00am
CORRESP
ysifrmsb
25 Apr 23
Correspondence with SEC
12:00am
CORRESP
e0622cvw7ifa tlrqb7
24 Apr 23
Correspondence with SEC
12:00am
CORRESP
cccl0i67gyh
24 Apr 23
Correspondence with SEC
12:00am